|
US 12,291,499 B2 |
|
| Deuterated tryptamine derivatives and methods of use |
| Alex Nivorozhkin, West Roxbury, MA (US) |
| Assigned to Cybin IRL Limited, Dublin (IE) |
| Filed by CYBIN IRL LIMITED, Dublin (IE) |
| Filed on Mar. 8, 2024, as Appl. No. 18/600,018. |
| Application 18/600,018 is a continuation of application No. 18/493,231, filed on Oct. 24, 2023, granted, now 11,958,807. |
| Application 18/493,231 is a continuation of application No. 18/172,691, filed on Feb. 22, 2023, granted, now 11,834,410. |
| Application 18/172,691 is a continuation of application No. 17/564,707, filed on Dec. 29, 2021, granted, now 11,724,985, issued on Jul. 26, 2023. |
| Application 17/564,707 is a continuation of application No. 17/394,038, filed on Aug. 4, 2021, granted, now 11,242,318, issued on Feb. 8, 2022. |
| Application 17/394,038 is a continuation of application No. PCT/IB2021/054340, filed on May 19, 2021. |
| Claims priority of provisional application 63/157,118, filed on Mar. 5, 2021. |
| Claims priority of provisional application 63/114,738, filed on Nov. 17, 2020. |
| Claims priority of provisional application 63/026,939, filed on May 19, 2020. |
| Prior Publication US 2024/0270691 A1, Aug. 15, 2024 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. C07D 209/16 (2006.01); A61K 9/20 (2006.01); A61K 31/4045 (2006.01) |
